Floracene (YC S26) — Vibecode + deploy HIPAA-compliant internal tools, no eng team needed
Floracene lets any healthcare operator describe the internal tool they need and deploy it in one click - connected to production data, with read and write access scoped by the user. Think Lovable or Retool, except purpose-built for the needs of healthcare business that has no engineering team.
Floracene is a Y Combinator company in the Summer 2026 batch. Its directory entry describes it as: Vibecode + deploy HIPAA-compliant internal tools, no eng team needed. The founders listed are Asaph Kupferman (Founder/CEO), Jonah Kaye (Founder/CTO) (Y Combinator directory entry, July 7, 2026).
Sell to companies like these? Paste your website and see 10 with a filed reason to buy this month. Free.
Opens in a new tab. No signup.
What it does Vibecode + deploy HIPAA-compliant internal tools, no eng team needed (source)
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
Floracene lets any healthcare operator describe the internal tool they need and deploy it in one click - connected to production data, with read and write access scoped by the user. Think Lovable or Retool, except purpose-built for the needs of healthcare business that has no engineering team.
The bottleneck in healthcare isn't building anymore. Anyone can vibecode an 80% solution in an afternoon, custom to their own workflow, with people already on staff. The tool then dies locally on the builder’s computer, because IT (correctly) won't let anyone deploy a tool touching PHI without first-class authentication and permissioning. Our first design partner had multiple employees who had each built useful tools and dashboards locally, but couldn’t actually share these with coworkers or connect to their core practice data. Within weeks of implementing Floracene, they were able to consolidate their BI tooling into Floracene and shipped 4 net-new to production.
A staggering ~$200B is spent on administrative software in healthcare every year in the US. Tens of thousands of those companies still run core operations on spreadsheets, and we're at the top of the first inning of AI adoption.
Asaph and Jonah met on the hospitals team at Palantir two years ago, and have each spent the last four years in the plumbing of US healthcare: claims, eligibility, and payor contracting. Asaph was an early PM at Garner. Jonah was a founding engineer at Metriport (YC S22) after starting his own fax-automation startup for fertility clinics.
What the site is built with
Next.jsframeworkVercelhosting
Read from the page's own HTML and response headers on 10 September 2026, at https://www.floracene.com/. Each badge matched a string the site serves about itself — hover one to see which. Nothing here is a traffic, ranking or revenue figure: those cannot be read off a page and are not claimed.
Checked away from the directory entry. What is below does not come from the company's Y Combinator page.
The title and description the site itself served, answering 200. Not a cached copy and not the company's directory entry — what was live when we asked.
Asaph Kupferman
Founder/CEO
Founder / CEO at Floracene (YC S26). Previously Hospitals team at Palantir and early employee at Garner Health.
Robotics / Electrical Engineering from Penn. Amateur chef.
Jonah Kaye
Founder/CTO
Founder / CTO at Floracene (YC S26). Previously Tech Lead at Palantir (Hospitals) and Founding Engineer at Metriport (YC S22).
CS and Philosophy @ UChicago. Brazilian Jiu Jitsu Brown Belt.
Founders, titles and bios as the company published them. Photographs are our own copies of the ones on that record, so they do not break when the original link expires.
No investor is drawn from a Form D — the form states how many invested and never who. The one investor on this graph is named because a batch has exactly one.
Weighing a deal with Floracene? A company due diligence report brings its funding, leadership changes, layoffs and warning signs together, with every claim linked to its source.
Want the whole picture on Floracene?
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Floracene: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Floracene covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
6 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
You get an alert in MentionFox the next time this company shows up.
Is this you?
If you're behind Floracene: acceptance into a YC batch is one of the few weeks a young company gets looked up by people who matter — investors, other founders, press. FoxPlug turns the commits, deploys, and releases you're already making into that story automatically, so anyone who looks finds something current. GetFoxChat puts a guide on your own site so the people YC's own page just sent you don't read one line and leave.
